Table 2.
Author | Year | Number of patients | Treatment | Number of patients with chronicity (%) | Number of patients with SGF (%) |
---|---|---|---|---|---|
Bouchenaki and Herbort30 | 2011 | 5 | CS+IST | 0 (0) | 0 (0) |
Abu El-Asrar et al.31 | 2017 | 38 | CS+MMF | 0 (0) | 0 (0) |
Lodhi et al.32 | 2017 | 24 | CS+AZA | 4 (17) | 6 (25) |
Yang et al.33 | 2018 | 105 | CS+IST | 0 (0) | 24 (23) |
Total | 172 | CS+IST | 4/172=2.3% | 30/172=17.5% |
SGF: Sunset-glow fundus, CS: Corticosteroid, IST: Diverse conventional and validated immunosuppressive treatments, MMF: Mycophenolate Mofetil, AZA: Azathioprine